Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Financial planning can be overwhelming. Find out where to start and set yourself on the path to financial success.
20,577 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
When a top investor steps up after a steep drop, it signals conviction. This deep dive looks at why First Beijing bou...
Is XRP poised to rival Bitcoin, or is it a specialized payments tool? This guide breaks down the risks, the upside, a...
WWDC 2026 sparked a hot debate: can Apple sustain profits without bold hardware innovation? This guide breaks down th...
Investors are resorting to a dividend-driven approach to cover a $1,500 monthly car payment without dipping into prin...
A new framework around Michael Saylor's strategy approach reshapes how Bitcoin is bought and sold. This article unpac...
Warren Buffett’s transition at Berkshire Hathaway puts Apple in the spotlight as the conglomerate’s largest public ho...
A notable investor exited a large Ethereum ETF and pivoted toward Bitcoin last quarter. This article explains what su...
The U.S. sits on a $38 trillion debt path that investors and households will feel long before any sudden crunch. Poli...
Investors eyes are on Hackett Group as 2026 unfolds. This guide breaks down how to read the Hackett Group (HCKT) 2026...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...